ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $21,248 | -79.7% | 4,118 | -75.8% | 0.00% | -100.0% |
| Q4 2018 | $104,455 | +5.0% | 17,040 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $99,514 | +1321.6% | 17,040 | +1104.2% | 0.00% | – |
| Q4 2017 | $7,000 | -96.2% | 1,415 | -95.3% | 0.00% | -100.0% |
| Q3 2017 | $186,000 | -15.5% | 30,359 | -0.3% | 0.00% | -50.0% |
| Q2 2017 | $220,000 | +61.8% | 30,449 | +18.9% | 0.00% | +100.0% |
| Q1 2017 | $136,000 | -12.8% | 25,619 | +17.9% | 0.00% | 0.0% |
| Q4 2016 | $156,000 | -26.8% | 21,736 | -4.4% | 0.00% | -50.0% |
| Q3 2016 | $213,000 | +31.5% | 22,738 | -11.6% | 0.00% | +100.0% |
| Q2 2016 | $162,000 | -7.4% | 25,709 | +24.3% | 0.00% | 0.0% |
| Q3 2015 | $175,000 | -42.6% | 20,686 | +2.6% | 0.00% | -50.0% |
| Q2 2015 | $305,000 | -3.8% | 20,168 | +1.8% | 0.00% | 0.0% |
| Q1 2015 | $317,000 | -19.5% | 19,810 | -10.5% | 0.00% | -33.3% |
| Q4 2014 | $394,000 | +100.0% | 22,138 | +12.8% | 0.00% | +200.0% |
| Q3 2014 | $197,000 | -35.6% | 19,624 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $306,000 | – | 19,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |